JOHN EDWARD ZEBER
Health Policy and Management
School of Public Health and Health Sciences
University of Massachusetts - Amherst
328 Arnold House, 715 Pleasant St. (413) 545-7481
Amherst MA 01003 jzeber@umass.edu
Education:
· University of Michigan Doctor of Philosophy (2004): Health Services Organization & Policy
(HSOP) – Sociology cognate
·
University of Washington Masters of Health Administration
(1998)
Teaching Assistant: Statistics, Quantitative Methods
Research Assistant: “Managed Care and Risk-Bearing Contracts”
·
Occidental College Bachelor
of Arts, Economics (1987)
Post-graduate Training:
·
University
of Texas Health Science Center, San Antonio – Multi-disciplinary
Clinical Research Scholars Training Program (K12) awardee (Fall 2006-Fall
2008).
·
Veterans
Affairs Health Services Research & Development (HSRD),
Summary of Research Interests, Experience, and Professional Goals:
Over the past decade conducting health services research, my primary objectives have focused on three issues: 1) health outcomes for patients with serious mental illness (schizophrenia, bipolar disorder, PTSD, depression); 2) barriers to medication and treatment adherence, along with the potential clinical and financial ramifications; 3) ethnicity, culture, and reducing disparities. I have gained a national reputation in these areas, including invited talks and conference presentations, plus several highly cited publications. I have served on two expert panels on medication adherence, one an ongoing international work group, with my studies on pharmacy copayments highlighting a VA report concerning policy effects. A Washington Post lead article featured my work on ethnic disparities in psychiatric diagnosis, followed by an invitation to speak at a Congressional Black Caucus event. Most recently, I accepted an offer to serve as guest journal editor for a special ethnicity issue of Depression Research & Treatment. From collaborative work across the VA and academic partnerships, I have also accumulated experience on projects pertaining to cost-effectiveness analysis, post-deployment experiences of veterans seeking VA care, and enhanced implementation of the chronic care model or patient-centered medical home principles. As I continue developing my research portfolio, I look forward to making contributions to my institutions and the wider research community, working in a leadership role within our newly established health outcome center to set a clincially significant research agenda, while also mentoring junior investigators.
Professional Experience:
University of Massachusetts - Amherst, School of Public Health and Health Sciences , Department of Health Promotion and Policy, Health Policy and Management: Associate
Professor and Program Head (September 2018-ongoing). Manage the program of studies of health policy and management, manage program courses, counsel students, teaching, course development, faculty collaboration, and research mentoring of students and faculty.
Texas A&M Health Science Center
(TAMHSC), Department of Medicine: Associate
Professor (approved, April 2011-2018). Occasional
lectures, course development, faculty collaboration, and research mentoring of
students, residents, and fellows.
Texas A&M School of Public
Health, Department of Health Promotion & Community Health Science: Adjunct Faculty (2011-2018). Research development, mentoring, and consultation.
University of Texas Health Science
Center at San Antonio (UTHSCSA), Department
of Psychiatry: Adjunct Faculty (Assistant Professor September 2006 – 2010). Active
involvement in funded projects, occasional lectures, interdisciplinary
research, and career development activities.
University of Texas School of Public
Health, Division of Management, Policy and Community
Health: Adjunct Faculty (April
2005 – present). Similar to above roles; also co-developed a course in Health Management and Policy, for
MHA program (Spring-Summer 2007)
Central Texas Veterans Health Care System –
Temple, TX (September 2010 to 2019): VA Investigator. Focused on reduction of hospital infection transmission in the Central Texas VA Medical Center using system and environmental change efforts.
Scott
& White Healthcare: Center for Applied Health Research (CAHR) and Central Texas
Veterans Health Care System –
Temple, TX (September 2010 to 2018): Co-Director, CAHR Health Outcomes Core / VA Investigator. Recruited to help start a new applied
health research and outcomes center at Scott & White, as a joint effort
with the Central Texas VA. Cross-divisional center devoted to translational and
outcomes research for patients for chronic medical and psychiatric conditions,
mentoring and professional development, and collaboration across HMO Research
Network members.
Veterans Evidence-Based Research,
Dissemination, and Implementation Center (VERDICT): South Texas Veterans Health
Care System HSRD – San Antonio, TX (2006-August 2010): Investigator.
A two-year post-doctoral appointment transitioned into full position as VA
investigator, with both practical research experience and ongoing didactic
education. Projects included dissertation follow-up efforts, other manuscripts,
collaboration with VA and university investigators, conference presentations,
and development of research grants. Ongoing collaboration on several projects, following
transition to positions in Temple.
Veterans
Administration Ann Arbor Healthcare System, Health Services Research &
Development (HSRD) – Ann Arbor, MI (1999-2004): Research
Associate
with the Serious Mental Illness Treatment Research and Evaluation Center
(SMITREC). Diverse responsibilities include grant preparation, database
management, literature reviews, authorship on papers, conference presentations,
involvement with special projects (e.g., national registry of veterans with
schizophrenia, medication adherence), survey coding, and data analysis.
Increasing emphasis in the specialty area of depression and schizophrenia
research topics.
Group Health
Cooperative –
Inland
Behavioral Medical Group – Upland, CA (1995): Provider
Relations Manager. Responsible for developing a psychiatric provider
network with a growing Independent Physicians Association (PA). Involved with
marketing, credentialing and database management.
Office
Management & Administrative
PLP & Associates – Pasadena, CA
(1991-1995): Business Manager. Sole responsibility for managing
psychological group and outpatient eating disorders clinic. Budgeting, payroll,
policy development, tax preparation, financial analysis, marketing, patient
intake, and managed care coordination for $500,000 practice. Discretion given
to initiate projects and explore business options.
Wanda B. Olsen, M.D. – Pasadena, CA
(1989-1990): Office Manager. Daily management of private psychiatry
office, billing/ receivables, scheduling, hospital coordination, patient
referrals, other responsibilities.
Las Encinas
Hospital – Pasadena, CA (1987-1989): Served in different nursing
roles, including private duty and floor capacities. Later appointed as
Admissions Supervisor / Acting Director, in addition to evening supervision.
Beverly
Enterprises – Riverside, CA (1984-1987): Numerous departments at
long-term psychiatric hospital during college vacations, including nursing
(certified nurses assistant), floor supervision, medical records, activities,
program coordination, and front office.
RESEARCH EXPERIENCE
Publications:
102)
Jager-Hyman S, Benjamin Wolk C, Ahmedani BK, Zeber JE, Fein JA, Brown GK, Byeon YV, Listerud H, Gregor CA, Lieberman A, Beidas RS.
Perspectives from firearm stakeholders on firearm safety promotion in pediatric primary care as a suicide prevention strategy: a qualitative study.
J Behav Med. 2019 Aug;42(4):691-701. 10.1007/s10865-019-00074-9. Epub 2019 Aug 1. PMID: 31367934
101)
Coppin JD, Villamaria FC, Williams MD, Copeland LA, Zeber JE, Jinadatha C. Increased time spent on terminal cleaning of patient rooms may not improve disinfection of high-touch surfaces. Infect Control Hosp Epidemiol. 2019 May;40(5):605-606. doi: 10.1017/ice.2019.44. Epub 2019 Mar 25. PMID: 30905326.
100)
Benjamin Wolk CB, Van Pelt AE, Jager-Hyman S, Ahmedani BK, Zeber JE, Fein JA, Brown GK, Gregor CA, Lieberman A, Beidas RS. Stakeholder Perspectives on Implementing a Firearm Safety Intervention in Pediatric Primary Care as a Universal Suicide Prevention Strategy: A Qualitative Study. JAMA Network Open 2018 Nov 2;1(7):e185309. doi: 10.1001/jamanetworkopen.2018.5309. PMID: 30646398.
99)
Pednekar P, Ágh T, Malmenas M, Raval AD, Bennett B, Borah BJ, Hutchins D, Manias EF, Williams AF, Hiligsmann M, Turcu-Stiolica A, Zeber JE, Abrahamyan L, Bunz TJ, Peterson AM. Methods for Measuring Multiple Medication Adherence: A Systematic Review-Report of the ISPOR Medication Adherence and Persistence Special Interest Group. Value in Health 2019 Feb;22(2):139-156. doi: 10.1016/j.jval.2018.08.006. Epub 2018 Oct 25. PMID: 30711058.
98)
Beidas RS, Jager-Hyman S, Becker-Haimes EM, Wolk CB, Ahmedani BK, Zeber JE, Fein JA, Brown GK, Gregor CA, Lieberman A, Marcus SC. Acceptability and use of evidence-based practices for safe firearm storage in pediatric primary care. Academic Pediatrics 2018 Nov 30. pii: S1876-2859(18)30753-8. doi: 10.1016/j.acap.2018.11.007. PMID: 30508600.
97)
Zeber JE, Pfeiffer C, Baddley JW, Cadena-Zuluaga J, Stock EM, Copeland LA, Hendricks J, Mohammadi J, Restrepo MI, Jinadatha C. Effect of pulsed xenon ultraviolet room disinfection devices on microbial counts for methicillin-resistant Staphylococcus aureus and aerobic bacterial colonies. Am J Infect Control 2018 Apr 11. pii: S0196-6553(18)30074-9. doi: 10.1016/j.ajic.2018.02.001. [Epub ahead of print] PMID: 29655672.
96)
Stock EM, Zeber JE, McNeal CJ, Banchs JE, Copeland LA. Psychotropic pharmacotherapy associated with QT prolongation among veterans with posttraumatic stress disorder. Ann Pharmacother 2018 Apr 1:1060028018769425. doi: 10.1177/1060028018769425. [Epub ahead of print] PMID: 29642718.
95)
Copeland LA, Zeber JE, Thibodeaux LV, McIntyre RT, Stock EM, Hochhalter AK. Postdischarge correlates of health literacy among Medicaid inpatients. Popul Health Manag 2018 Mar 29. doi: 10.1089/pop.2017.0095. [Epub ahead of print] PMID: 29596034.
94)
Waitzfelder B, Stewart C, Coleman KJ, Rossom R, Ahmedani BK, Beck A, Zeber JE, Daida YG, Trinacty C, Hubley S, Simon GE. Treatment initiation for new episodes of depression in primary care settings. J Gen Intern Med. 2018 Feb 8. doi: 10.1007/s11606-017-4297-2. [Epub ahead of print] PMID: 29423624
93)
Cho J, Stock EM, Liao IC, Zeber JE, Ahmedani BK, Basu R, Quinn CC, Copeland LA. Multiple chronic condition profiles and survival among oldest-old male patients with hip fracture. Arch Gerontol Geriatr. 2018 Jan;74:184-190. doi: 10.1016/j.archger.2017.10.014. Epub 2017 Oct 28. PMID: 29126081
92)
Stock EM, Stamey JD, Zeber JE, Thompson AW, Copeland LA. A Bayesian approach to modeling risk of hospital admissions associated with schizophrenia accounting for under-diagnosis of the disorder in administrative records. Computational Psychiatry 2018 Feb 1;2:1-10. doi: 10.1162/CPSY_a_00010. eCollection 2018 Feb. PMID: 30090859.
91)
Zeber JE, Coleman KJ, Fischer H, Yoon TK, Ahmedani BK, Beck A, Hubley S, Imel ZE, Rossom RC, Shortreed SM, Stewart C, Waitzfelder BE, Simon GE. The impact of race and ethnicity on rates of return to psychotherapy for depression. Depress Anxiety 2017 Dec;34(12):1157-1163. doi: 10.1002/da.22696. Epub 2017 Nov 2. PMID: 29095538
90)
Wolk CB, Jager-Hyman S, Marcus SC, Ahmedani BK, Zeber JE, Fein JA, Brown GK, Lieberman A, Beidas RS. Developing implementation strategies for firearm safety promotion in paediatric primary care for suicide prevention in two large US health systems: a study protocol for a mixed-methods implementation study. BMJ Open. 2017 Jun 24;7(6):e014407. doi: 10.1136/bmjopen-2016-014407. PMID: 28647722.
89)
Coppin JD, Villamaria FC, Williams MD, Copeland LA, Zeber JE, Jinadatha C. Self-sanitizing copper-impregnated surfaces for bioburden reduction in patient rooms. Am J Infect Control 2017 Jun 1;45(6):692-694. doi: 10.1016/j.ajic.2017.01.012. Epub 2017 Feb 22. PMID: 28237738
88) Stock EM, Copeland LA, Tsan JY, Zeber JE, Veronin M, Thompson AW. Association of hospitalization with first-line antidepressant polypharmacy among Veterans of Iraq and Afghanistan with PTSD: Examining the influence of methodological approaches. Mil Med 2016 Oct;181(10):1248-1257. PMID: 27753560.
87) Cho J, Copeland LA, Stock EM, Zeber JE, Restrepo MI, MacCarthy AA, Ory MG, Smith PA, Stevens AB. Protective and risk factors for 5-year survival in the oldest old veterans: data from the Veterans Health Administration. J Am Geriatr Soc 2016 Jun;64(6):1250-7. doi: 10.1111/jgs.14161. PMID: 27321603.
86) Basu R, Zeber JE, Copeland LA, Stevens SB. Role of co-existence of multiple chronic conditions on the longitudinal decline in cognitive performance among older adults in the US. J Gerontol Geriat Res 2016 Jan-Feb;14(1):54-62. doi: 10.1370/afm.1885. PMID: 26755784.
85) Coleman KJ, Stewart C, Waitzfelder BE, Zeber JE, Morales LS, Ahmed AT, Ahmedani BK, Beck A, Copeland LA, Cummings JR, Hunkeler EM, Lindberg NM, Lynch F, Lu CY, Owen-Smith AA, Trinacty CM, Whitebird RR, Simon GE. Racial-Ethnic Differences in Psychiatric Diagnoses and Treatment Across 11 Health Care Systems in the Mental Health Research Network. Psychiatr Serv. 2016 Apr 15:appips201500217. [Epub ahead of print] PMID: 27079987.
84) Blackburn DR, Romers CC, Copeland LA, Lynch W, Nguyen DD, Zeber JE, Hoffman MR. Presurgical Psychological Assessments as Correlates of Effectiveness of Spinal Cord Stimulation for Chronic Pain Reduction. Neuromodulation. 2016 Mar 29. doi: 10.1111/ner.12431. [Epub ahead of print] PMID: 27028312.
83) Dixon JL, Copeland LA, Zeber JE, MacCarthy AA, Reznik SI, Smythe WR, Rascoe PA.Association between diabetes and esophageal cancer, independent of obesity, in the United States Veterans Affairs population. Dis Esophagus. 2015 Oct 12. doi: 10.1111/dote.12402. [Epub ahead of print]. PMID: 26455587.
82) Villamaria FC, Berlanga G, Liao IC, Ganachari-Mallappa N, Stock EM, Zeber JE, Jinadatha C.Comparison of Environmental MRSA Levels on High-Touch Surfaces in Contact Isolation and Noncontact Isolation Patient Rooms. Infect Control Hosp Epidemiol. 2015 Dec;36(12):1472-5. doi: 10.1017/ice.2015.207. Epub 2015 Aug 27. PMID: 26311001.
81) Copeland LA, Zeber JE, Sako EY, Mortensen EM, Pugh MJ, Wang CP, Restrepo MI, Flynn J, MacCarthy AA, Lawrence VA. Serious mental illnesses associated with receipt of surgery in retrospective analysis of patients in the Veterans Health Administration. BMC Surg 2015 Jun 18;15:74. doi: 10.1186/s12893-015-0064-7. PMID: 26084521.
80) Jinadatha C, Villamaria FC, Restrepo MI, Ganachari-Mallappa N, Liao I, Stock EM, Copeland LA, Zeber JE. Is the pulsed xenon ultraviolet light no-touch disinfection system effective on methicillin-resistant Staphylococcus aureus in the absence of manual cleaning? American Journal of Infection Control. 2015 Aug;43(8):878-81. doi: 10.1016/j.ajic.2015.04.005. Epub 2015 May 23. PMID: 26014583.
79) Hutchins D, Zeber JE, Roberts C, Williams AF, Manias EF, Peterson AM. Initial medication adherence - review and recommendations for good practices for outcomes research: an ISPOR medication adherence and persistence special interest group report. Value in Health. 2015 Jul;18(5):690-9. doi: 10.1016/j.jval.2015.02.015. Epub 2015 May 16. Review. PMID: 26297098.
78) Jinadatha C, Villamaria FC, Copeland LA, Ganachari-Mallappa N, Brown DS, Liao I, Stock EM, Zeber JE (2015). Can pulsed xenon ultraviolet disinfect aerobic bacteria in the absence of manual disinfection? American Journal of Infection Control, 43:415-7.
77) Evans LD, Stock EM, Zeber JE, Morissette SB, MacCarthy AA, Sako EY, Lappin J, Lawrence VA, MacCarthy DJ, Copeland LA (2015). Post-transplantation outcomes in veterans with serious mental illness. Transplantation Feb 20 [epub ahead of print; DOI: 10.1097/TP.0000000000000616]. PMID: 25706275.
76) Tsan JY, Stock EM, Greenawalt DS, Zeber JE, Copeland LA (2014). Mental health utilization before and after major surgery among Vietnam era veterans with post-traumatic stress disorder. Journal of Health Psychology Oct 10. pii: 1359105314551620. PMID 25305191.
75) Phillips KL, Copeland LA, Zeber JE, EM Stock, Tsan JY, MacCarthy AA (2014). Racial/ethnic disparities in monitoring and treating metabolic parameters for patients with schizophrenia receiving antipsychotic medications. American Journal of Geriatric Psychiatry Jul 30. pii: S1064-7481(14)00221-8. PMID 25154537.
74) Stock EM, Kimbrel NA, Meyer EC, Copeland LA, Monte R, Zeber JE, Gulliver SB, Morissette SB (2014). A Bayesian model averaging approach to examining changes in quality of life during reintegration into civilian life among returning Iraq and Afghanistan veterans. International Journal of Methods in Psychiatric Research, 23(3):345-5.
73) Copeland LA, Sako EY, Zeber JE, Pugh MJ, Wang CP, MacCarthy AA, Restrepo MI, Mortensen EM, Flynn J, Lawrence VA (2014). Mortality after Cardiac Operations by Pre-Existing Severe Mental Illness Status. General Hospital Psychiatry, 36(5):502-8.
72) Copeland LA McIntyre R, Stock E,
Zeber JE, MacCarthy DJ, Pugh MJ. (2014). Prevalence of suicidality among hispanic and african-american patients following surgery. American Journal of Public Health, 104(S4):603.
71) Sun FF, Stock EM, Copeland LA,
Zeber JE, Ahmedani BK, Morissette SB. (2014). Comparison of antipsychotic polypharmacy trends among schizophrenia patients across multiple healthcare systems. American Journal of Health Systems Pharmacy, 71(9):728-38.
70) Jinadatha C, Quezada R, Huber TW, Williams JB, Zeber JE, Copeland LA. (2014). Evaluation of a pulsed-xenon ultraviolet room disinfection device for impact on contamination levels of methicillin-resistant staphylococcus aureus. BMC Infectious Diseases, 14:187.
69) Noel PH, Parchman ML, Palmer RF, Romero RL, Leykum LK, Lanham HJ, Zeber JE, Bowers KW.
Alignment of patient and primary care practice member perspectives of chronic illness care: a cross-sectional analysis. BMC Fam Pract. 2014 Mar 29;15:57. doi: 10.1186/1471-2296-15-57. PMID: 24678983.
68) Penfold
RB, Stewart C, Hunkeler EM, Madden JM, Cummings JR, Owen-Smith AA, Rossom RC,
Lu CY, Lynch FL, Waitzfelder BE, Coleman KJ, Ahmedani BK, Beck AL, Zeber JE,
Simon GE. Use of antipsychotic medications in pediatric populations: what do
the data say? Curr Psychiatry Rep. 2013 Dec;15(12):426. doi:
10.1007/s11920-013-0426-8. Erratum in: Curr Psychiatry Rep. 2014 Feb;16(2):432.
Coleman, Karen A [corrected to Coleman, Karen J]. PMID: 24258527.
67) Greenawalt
DS, Copeland LA, MacCarthy AA, Sun FF, Zeber JE. Posttraumatic stress
disorder and odds of major invasive procedures among U.S. Veterans Affairs
patients. J Psychosom Res. 2013 Oct;75(4):386-93. doi: 10.1016/j.jpsychores.2013.08.012.
Epub 2013 Aug 26. PMID: 24119948.
66) Copeland
LA, Zeber JE. Advancing research in the era of healthcare reform: the
19th annual HMO Research Network Conference, April 16-18, 2013, San Francisco,
California. Clin Med Res. 2013 Sep;11(3):120-2. doi:
10.3121/cmr.2013.1175. No abstract available. PMID: 24085855.
65) Stock
EM, Copeland LA, Bush RL, Zeber JE. Datapoints: Prevalence of QT
prolongation among veterans with severe mental illness. Psychiatr Serv.
2013 Oct;64(10):942. doi: 10.1176/appi.ps.201300212. No abstract available.
PMID: 24081399.
64) Zeber
JE, Manias E, Williams AF, Hutchins D, Udezi WA, Roberts CS, Peterson AM;
ISPOR Medication Adherence Good Research Practices Working Group. A systematic
literature review of psychosocial and behavioral factors associated with
initial medication adherence: a report of the ISPOR medication adherence &
persistence special interest group. Value Health. 2013
Jul-Aug;16(5):891-900. doi: 10.1016/j.jval.2013.04.014. Epub 2013 Jul 10. Review.
PMID: 23947984.
63) Culler
SD, Parchman ML, Lozano-Romero R, Noel PH, Lanham HJ, Leykum LK, Zeber JE.
Cost estimates for operating a primary care practice facilitation program. Ann
Fam Med. 2013 May-Jun;11(3):207-11. doi: 10.1370/afm.1496. PMID: 23690319.
62) Pugh
MJ, Marcum ZA, Copeland LA, Mortensen EM, Zeber JE, Noël PH, Berlowitz
DR, Downs JR, Good CB, Alvarez C, Amuan ME, Hanlon JT. The quality of quality
measures: HEDIS® quality measures for medication management in the elderly and
outcomes associated with new exposure. Drugs Aging. 2013
Aug;30(8):645-54. doi: 10.1007/s40266-013-0086-8. PMID: 23645530.
61) Tsan
JY, Stock EM, Gonzalez JM, Greenawalt DS, Zeber JE, Rouf E, Copeland LA.
Mortality and guideline-concordant care for older patients with schizophrenia:
a retrospective longitudinal study. BMC Med. 2012 Nov 26;10:147. doi:
10.1186/1741-7015-10-147. PMID: 23181341.
60) Pugh
MJ, Copeland LA, Zeber JE, Wang CP, Amuan ME, Mortensen EM, Tabares JV,
Van Cott AC, Cooper TL, Cramer JA. Antiepileptic drug monotherapy exposure and
suicide-related behavior in older veterans. J Am Geriatr Soc. 2012
Nov;60(11):2042-7. doi: 10.1111/j.1532-5415.2012.04207.x. Epub 2012 Oct 30.
PMID: 23110401.
59) Williams
EO, Stock EM, Zeber JE, Copeland LA, Miller NA, Stuart M, Palumbo F.
Payer characteristics associated with antipsychotic polypharmacy in an
ambulatory care setting. J Pharm Health Serv Res. 2012 3(3): 149-155. Online: 5 APR 2012 DOI: 10.1111/j.1759-8893.2012.00083.x.
58) Copeland
LA, Zeber JE, Pugh MJ, Phillips KL, Lawrence VA. "Ethnicity and
Race Variations in Receipt of Surgery among Veterans with and without
Depression”. Depress Res Treat.
2011;370962. doi: 10.1155/2011/370962. Epub 2011 Oct 12. PMID: 22013518.
57) Mackey
K, Parchman MP, Leykum LK, Lanham HJ, Noel PH, Zeber JE. “Impact of the
Chronic Care Model on medication adherence when patients perceive cost as a
barrier”. Prim Care Diabetes. 2012
Jul;6(2):137-42. doi: 10.1016/j.pcd.2011.12.004. Epub 2012 Jan 20. PMID:
22264426.
56) Tsan
J, Zeber JE, Stock EM, Sun FF, Copeland LA. “Primary care mental health
integration and treatment retention among Iraq and Afghanistan war veterans”. Psychological Services. 2012
Nov;9(4):336-48. doi: 10.1037/a0028308. Epub 2012 Apr 30. PMID: 22545824.
55) Arar
N, Noel PH, Leykum LK, Zeber JE, Romero R, Parchman ML. “Implementing
quality improvement in small, autonomous primary care practices: implications
for the patient-centred medical home.” Quality
in Primary Care. 2011; 19(5):289-300. PMID: 22186171.
54) Maples
NJ, Copeland LA, Zeber JE, Li X, Moore TA, Dassori D, Velligan DI,
Miller AL. “Can medication management coordinators help improve continuity of
care after psychiatric hospitalization?”. Psychiatric
Services. 2012 Jun;63(6):554-60. doi: 10.1176/appi.ps.201100264. PMID:
22476107.
53) Zeber
JE, Gonzalez JM, VanDorn RA, Interian A. “Ethnicity and cultural issues”. Depress Res Treat. [2011;2011:195084.
doi: 10.1155/2011/195084. Epub 2011 Oct 30. No abstract available. PMID:
22110911.
52) Copeland
LA, Zeber JE, Pugh MJ, Phillips KM, Lawrence VA. Ethnicity and race
variations in receipt of surgery among veterans with and without depression. Depress Res Treat. 2011; 370962. Epub
2011 Oct 12. PMID 22013518.
51) Noel
PH, Zeber JE, Pugh MJ, Finley EP, Parchman ML. “A pilot survey of
post-deployment health care needs in small community-based primary care
clinics”. BMC Family Medicine; 2011
Jul 29; 12:79].
50) Copeland
LA, Ettinger AB, Zeber JE, Gonzalez JM, Pugh MJ (2011). “Psychiatric and
medical admissions observed among elderly patients with new-onset epilepsy”. BMC Health Services Research, 11:84.
49) Copeland LA, Zeber JE, Bingham MO, Pugh
MJ, Noël PH, Schmacker ER, Lawrence VA. (2011). “Transition
from military to VHA care: Psychiatric health services for Iraq/Afghanistan
combat-wounded”. Journal of Affective Disorders, 130(1-2):226-30.
48) Zeber
JE, Miller AL, Copeland LA, McCarthy JF, Zivin K, Valenstein M, Greenwald
D, Kilbourne AM. (2011) “Medication adherence, ethnicity, and the
influence of multiple psychosocial and financial barriers.”
Administration & Policy in Mental
Health / Mental Health Services Research, 38(2):86-95.
47) Dassori AM, Copeland LA, Zeber
JE, Miller AL. (2011). “Factors in second-generation antipsychotic switching
patterns in a national sample of older veterans with schizophrenia”. Psychiatric Services, 62(1):47-53.
46)
Gonzalez JM, Alegria M, Prihoda TJ,
Copeland LA, Zeber JE. (2011). ”How the
relationship of attitudes toward mental health treatment and service use
differs by age, gender, ethnicity/race and education”. Social Psychiatry & Psychiatric Epidemiology, 46(1):45-57.
45) Finley EP, Zeber JE,
Pugh MJ, Cantu G, Copeland LA, Parchman ML, Noel PH. (2010). “Postdeployment
healthcare for returning OEF/OIF military personnel and their social networks:
a qualitative approach”. Military
Medicine, 175(12):953-7.
44) Zeber
JE, Noel PH, Pugh MJ, Copeland LA, Parchman ML. (2010). “Family perceptions
of post-deployment healthcare needs of Iraq/Afghanistan military personnel”. Mental Health in Family Medicine,
7(3):135-43.
43) Zeber
JE, Copeland LA, Pugh MJ. (2010). “Variation in antiepileptic drug
adherence among older patients with new-onset epilepsy”. Annals of Pharmacotherapy, 44(12):1896-904.
42) McCarthy
JF, Valenstein M, Zivin K, Zeber JE, Kilbourne AM. (2010). ” Access-related measures and out-of-system utilization
among veterans with bipolar disorder”. Psychiatric
Services, 61(10):1035-8.
41) Copeland LA, Parchman ML,
Zeber JE, Lawrence VA, Downs JR, Miller AL. (2010). “Prediabetes assessment and follow-up in older
veterans with schizophrenia”. American
Journal of Geriatric Psychiatry, 18(10):887-96.
40) Parchman
ML, Zeber JE, Palmer RF. (2010). ”Participatory decision making, patient
activation, medication adherence and intermediate clinical outcomes in type 2
diabetes: a STARNet study”. Annals of
Family Medicine, 8(5):410-7.
39) Zeber
JE, Parchman ML. (2010). “Cardiovascular disease in type 2 diabetes: attributable risk
due to modifiable risk factors”. Canadian Family Physician, 56(8):e302-7.
38) Van
Cott AC, Cramer JA, Copeland LA, Zeber JE, Steinman MA, Dersh JJ,
Glickman ME, Mortensen EM, Amuan ME, Pugh MJ. (2010). “Suicide-related
behaviors in older patients with new anti-epileptic drug use: data from the VA
Hospital System”. BMC Medicine, 8:4.
37) Ettinger
AB, Copeland LA, Zeber JE, Van Cott AC, Pugh MJ. (2010). “Are
psychiatric disorders independent risk factors for new-onset epilepsy in older
individuals?” Epilepsy & Behavior,
17(1):70-4.
36)
Evans-Lacko SE, Zeber JE,
Gonzalez JM, Olvera RL. (2009). “Medical comorbidity among youth diagnosed with
bipolar disorder in the United States.“ Journal of Clinical Psychiatry, 70(10):1461-66.
35)
Medication Adherence Expert
Panel (Velligan DI, chair). (2009) “The expert consensus
guideline series: adherence problems in patients with serious and persistent
mental illness.” Journal of Clinical
Psychiatry, 70(suppl 4):1-46.
34) Perron
BE, Zeber JE, Kilbourne AM, Bauer MS. (2009). “A brief measure of
perceived clinician support by patients with bipolar spectrum disorders”. Journal of Nervous and Mental Disorders,
197(8):574-9.
33) Copeland
LA, Zeber JE, Wang CP, Lawrence VA, Parchman ML, Lawrence VA, Valenstein
M, Miller AL. (2009). “Patterns of primary care and mortality among patients
with schizophrenia or diabetes: a cluster analysis approach to the
retrospective study of healthcare utilization”. BMC Health Services Research, 9:127-37.
32) Hope OA, Zeber JE, Kressin NR, Bokhour BG, VanCott AC,
Cramer JA, Amuan ME, Knoefel JE, Pugh MJ. (2009). “New-onset geriatric epilepsy
care: race, setting of diagnosis, and choice of antiepileptic drug”. Epilepsia, 50(5):1085-93.
31) Ilgen MA, Czyz EK, Welsh
DE, Zeber JE, Bauer MS, Kilbourne AM. (2009). “A collaborative therapeutic relationship and risk of suicidal
ideation in patients with bipolar disorder”. Journal of Affective Disorders, 115(1-2):246-51.
30) Copeland
LA, Miller AL, Welsh DE, McCarthy JF, Zeber JE, Kilbourne AM. (2009). “Clinical and demographic factors associated with homelessness
and incarceration among VA patients with bipolar disorder”. American Journal of Public Health,
99(5):871-77.
29) Zeber JE, Copeland LA, McCarthy JF, Bauer MS,
Kilbourne AM. (2009). “Perceived access to general medical and
psychiatric care among veterans with bipolar disorder”. American Journal of Public Health,
99(4):720-7.
28) Zeber
JE, Pearson D, Smith D. (2009). “Analysis of health appointment no-shows”. Primary Health Care, 19(2):25-9.
27) Copeland LA, Lawrence VA, Zeber JE.
(2009). “Depression and the long-term effects on postoperative
outcomes [letter]”. Annals of Surgery, 249(2):353-4.
26) Zeber JE, Copeland LA, Hosek BJ, Karnad
AB, Lawrence VA, Sanchez-Reilly SE. (2008).
“Cancer rates, medical comorbidities, and treatment modalities in the oldest
patients”. Critical Reviews in Oncology
/Hematology, 67(3):237-42.
25) Pugh
MJ, Zeber JE, Copeland LA, Tabares JV, Cramer JA. (2008). “Psychiatric disease burden profiles among
veterans with epilepsy: the association with health services utilization”. Psychiatric Services, 59(8):925-8.
24) Copeland LA, Zeber JE, Pugh MJ,
Mortensen EM, Restrepo MI, Lawrence VA. (2008).
“Postoperative complications in the seriously mentally ill: a systematic review
of the literature". Annals of
Surgery, 281(1):31-8.
23) Velligan
DI, Diamond PM, Mintz J, Maples N, Li X, Zeber JE, Ereshefsky L, Lam YW,
Castillo D, Miller AL. (2008). “The use of individually tailored environmental
supports to improve medication adherence and outcomes in schizophrenia”. Schizophrenia Bulletin, 34(3):483-93.
22) Zeber
JE, Copeland LA, Good CB, Fine MJ, Bauer MS, Kilbourne AM. (2008).
“Therapeutic alliance perceptions and medication adherence in patients with
bipolar disorder”. Journal of Affective
Disorders, 107(1-3):53-62.
21) Copeland LA, Zeber JE, Salloum IM, Pincus
HA, Fine MJ, Kilbourne AM. (2008). “Treatment adherence and illness insight in
veterans with bipolar disorder”. Journal
of Nervous and Mental Disorders, 196(1):16-21.
20) Noël
PH, Parchman ML, Williams JW Jr, Cornell JE, Shuko L, Zeber JE, Kazis
LE, Lee AF, Pugh JA. (2007). “The challenges of multimorbidity from the patient
perspective” Journal of General Internal
Medicine, 22(supp3):419-24.
19) Parchman ML, Zeber JE, Romero RR, Pugh
JA. (2007). “Risk of coronary artery
disease in type 2 diabetes and the delivery of care consistent with the chronic
care model in primary care settings: A STARNet Study”. Medical Care, 45(12):1129-34.
17) Cornell JE, Pugh JA, Williams JW, Kazis L, Lee
AF, Parchman ML, Zeber JE, Pederson T, Montgomery KA, Noël PH. (2007). “Multimorbidity
clusters: clustering binary data from multimorbidity clusters: clustering
binary data from a large administrative medical database”. Applied Multivariate Research, 12(3):163-82.
16) Zeber
JE, Grazier KL, Valenstein M, Blow FC, Lantz PM. (2007). “Effect of a
medication copayment increase in veterans with schizophrenia”. American Journal of Managed Care, 13(6,
part 2):335-46.
15) Zeber
JE, Copeland LA, Amuan M, Cramer JA, Pugh MJ. (2007). “The role of comorbid
psychiatric conditions in health status in epilepsy”. Epilepsy and Behavior, 10(4): 539-46.
14) Kilbourne
AM, Post EP, Bauer MS, Zeber
JE, Copeland LA, Good CB, Pincus HA. (2007). “Therapeutic
drug and cardiovascular disease risk monitoring in patients with bipolar
disorder”. Journal of Affective Disorders,
102(1-3):145-51.
13) Zeber
JE, McCarthy JF, Bauer MS, Kilbourne AM. (2007). “Datapoints: self-reported
access to general medical and psychiatric care among veterans with bipolar
disorder”. Psychiatric Services, 58(6):740.
12) Copeland LA, Mortensen EM, Zeber JE,
Pugh MJ, Restrepo MI, Dalack GW. (2007). “Pulmonary disease among inpatient
decedents: Impact of schizophrenia”. Progress
in Neuro-Psychopharmacology & Biological Psychiatry, 31(3):720-6
11) Pugh MJ, Hanlon JT, Zeber JE, Bierman
A, Cornell J, Berlowitz DR. (2006).
“Assessing potentially inappropriate prescribing in the elderly Veterans
Affairs population using the HEDIS 2006 quality measure”. Journal of Managed Care Pharmacy, 12(7):537-45.
10) Zeber JE, Copeland LA, Grazier KL. (2006).
“Serious mental illness, aging, and
utilization patterns among veterans”. Military
Medicine, 171(7):619-26.
9) Copeland
LA, Zeber JE, Rosenheck RA, Miller AL. (2006). “Unforeseen inpatient mortality among veterans with
schizophrenia”. Medical Care,
44(2):110-6.
8) Pugh
MJ, Copeland LA, Zeber JE, Cramer JA, Amuan ME, Cavosos JE, Kazis LE.
(2005). “The impact of epilepsy on
health status among younger and older adults”.
Epilepsia, 46(11):1820-7.
7) Blow
FC, Zeber JE, McCarthy JF, Valenstein M, Gillon L, Bingham CR. (2004).
“Ethnicity and diagnostic patterns in veterans with psychoses”. Social
Psychiatry & Psychiatric Epidemiology, 39(10):841-51.
6) Valenstein
M, Blow FC, Copeland LA, McCarthy JF, Zeber JE, Gillon L, Bingham CR,
Stavenger T. (2004). “Poor antipsychotic adherence among patients with
schizophrenia: medication and patient factors”. Schizophrenia Bulletin, 30(2):255-64.
5) Copeland LA, Zeber JE, Valenstein M,
Blow FC. (2003). “Racial disparity in the use of atypical antipsychotic
medications among veterans”. American Journal of Psychiatry,
160(10):1817-22.
4) Barry KL, Zeber JE, Blow FC,
Valenstein M. (2003). “Effect of strengths model versus assertive community
treatment model on participant outcomes and utilization: two-year follow-up”. Psychiatric Rehabilitation Journal,
26(3):268-77.
3) Valenstein M, Copeland LA, Blow FC, McCarthy
JF, Zeber JE, Gillon L, Bingham CR, Stavenger T. (2002). “Pharmacy data
identify poorly adherent patients with schizophrenia at increased risk for
admission”. Medical Care,
40(8):630-9.
2) Valenstein M, Vijan S, Zeber JE.
(2002). “Should we screen for depression in primary care” [letter]. Annals of Internal Medicine, 136(5):412.
1) Valenstein M, Vijan S, Zeber JE,
Boehm K, Buttar A. (2001). “The cost-utility of screening for depression in
primary care”. Annals of Internal Medicine: 134(5): 345-60. [featured article,
with editorial]
Zeber JE, Copeland LA, Miller AL, Kilbourne AM, Velligan D.
“Ethnicity and the impact of higher medication copayments among veterans with
schizophrenia”.
Zeber JE, Copeland LA, Pugh MJ, Mortensen EM,
Book Chapters:
Epidemiology
of co-occurring TBI and PTSD [invitation to contribute to textbook
in progress (Oxford Press) on PTSD, Traumatic Brain Injury, and Returning
OEF/OIF Service Personnel – Copeland LA, Pugh MJ, Finley EP, Zeber JE].
Risk
Bearing and Capital Financing Arrangements in Integrated Health Systems:
Concepts and Cases. With Douglas Conrad, Ph.D,
Interviews
/ Press Articles / Newsletters:
Prescriptions
for Progress, September 2007 (vol.2, no.1) and December
2007 issues (vol.2, no.2): Two policy newsletters presenting my work on
copayments, ethnicity, and clinical impact.
CNS
Senior Care, June 2006 issue: brief telephone interview and
article on issues pertaining to ethnicity, cultural competency, potential
diagnostic or treatment disparities, and policy issues among the elderly with
mental health disorders (e.g., medication copayments).
Washington
Post, June
2005: “Racial Disparities Found in Pinpointing Mental Illness” (6/28/05); includes interview with JE Zeber,
based upon 2 published studies pertaining to ethnic differences in diagnosis
and treatment – part for a series on the subject of
mental illness and cultural factors.
Medical Post, June
2004: “Atypicals may aid compliance in schizophrenics”. Vol 40, Issue 22 (http://www.medicalpost.com).
Grants
FUNDED:
Primary Investigator
Post-Marketing Observational Cardiovascular Safety Study in Patients Taking Naloxegol. . [AstraZeneca (04/2015-03/2022, J E Zeber - PI)] $2.2M.
Examine long-term outcomes of new FDA-approved medication targeting side effects of chronic opioid use, including mortality and cardiovascular events.
Pulsed
Xenon Technology Targeting Hospital-Acquired Infections, Cost and Outcomes. [VA HSRD (04/2013-03/2016, J E Zeber - PI)] $761,292.
Evaluate the effect of implementing adjunct room cleaning with pulsed
ultraviolet light on rates of MRSA, other healthcare-acquired infections, and
associated costs.
Post-Deployment Health and Transition
into VA Care [VA Locally Initiated Project #66-014, John Zeber, PI] –
approved and funded for 2009, $50,000. Interview returning OEF military
personnel and community providers regarding treatment needs, access issues,
comfort providing care, and possible transition into the VA health system.
Effect
of Copayments among Veterans with Bipolar Disorder [Lilly grant, John Zeber, PI] – approved and funded for 2010,
$56,556. Examine the effect of higher VA medication copayments on prescriptions
for mood stabilizers and atypical antipsychotics, along with health services
utilization and costs (ER, hospital). [currently on hold pending relocation]
Post-Operative
Outcomes and Safety in Schizophrenic Elders
[Veterans Affairs VISN 17 grant, John Zeber, PI] – approved and funded
for 2008-2009 ($100,000). Secondary database
analysis collecting pilot data on potential differences in surgery rates and
outcomes between patients with serious mental illness (schizophrenia, bipolar,
PTSD) and veterans without psychiatric conditions. Study will explore issues of
competing demands and treatment delays leading to greater surgical needs and
clinical ramifications (e.g., relapse rates, mortality).
Medication Adherence, Outcomes and
Quality of Life Perceptions [PhRMA Foundation young investigator research
starter grant, John Zeber, PI] – approved and funded for 2007-2008
($60,000). Explore multidimensional aspects of medication adherence in patients
with schizophrenia, plus quality of life and health status outcomes. In a
national cohort study of schizophrenia patients receiving care between
1999-2005 (N=90,000): 1) statistically identify clinically-relevant adherence
sub-groups; 2) compare groups across multiple administrative and SF-36
variables; 3) assess quality of life by mapping SF-36 values to utilities.
Other outcomes include associating adherence / preferences to utilization and
pharmacy costs.
Multi-disciplinary Clinical Training
Program awardee [University of Texas Health Science Center at
Aging and Serious Mental Illness among
Veterans. Veteran Affairs Locally Initiating Project (LIP - #41-095). Small
grant program for young investigators [John Zeber, PI] – approved and
funded in August 2002, $10,000. Local funding for independent project examining
the association between age, psychiatric diagnosis, and utilization.
FUNDED: Co-Investigator / other
Healthcare Surfaces Disinfection: Investigation into the Antibacterial Effect of Copper-Infused Surfaces for Patient Rooms. .
[AHRQ (05/2019-05/2024, C Jinadatha - PI]. This R01 will examine the impact of installing copper-infused high-touch surfaces in patient rooms (tray tables, bathroom handrails, etc.) and in common areas such as nursing stations.
Intervention Mapping to Develop Multi-level Implementation Strategies in Partnership with Stakeholders: Firearms Means Restriction for Suicide Prevention in Pediatric Primary Care (ASPIRE).
[NIMH (2016-2018, R S Beidas - PI]. This study applies mixed methods to understand stakeholder perceptions about firearms education in primary care settings.
Trans-America Consortium of the HCSRN for the PMI (c) Cohort Program. .
[NIH PMI (2016-2019, B Ahmedani - PI]. This project will collect biospeciman data from local MHRN partner sites as part of a national study to develop tailored patient care algorithms and improve outcomes through personalized medicine.
Mental Health Research Network (MHRN) II.
[#2U19MH092201-04 NIMH (08/2014-07/2019, G E Simon - PI]. MHRN II will extend the Mental Health Research Network to develop novel methods and EMR-integrated infrastructure and conduct system-focused research in mental health including acute-phase depression treatment, behavioral activation psychotherapy for depression in pregnancy, Autism Spectrum Disorder (registry development), and the effect of FDA advisories on suicide risk in relation to antidepressant prescribing practices.
Hybrid
Strategies to Improve Health Care’s Triple Aims: Lessons Learned From the
Transformations of Two Health Systems.
[Commonwealth Fund (08/01/2012-07/31/2014, R Reid - PI)]. The project will use
qualitative and quantitative methods to describe and contrast the system-level
transformations, motivations and processes in two health care systems 2005-2009
undergoing payer-provider restructuring, and to assess the impact on providers,
patients, quality of care and costs.
Evaluation of a Pulsed-Xenon
Ultraviolet Room Disinfection Device for Impact on contamination levels of C.diff
and MRSA [Xenex] – Chetan Jinadatha, PI. (5% effort as Co-I); approved
for FY12, $125,000 Examine clinical and cost-effectiveness of an automated
disinfection device.
Surgical Treatment Outcomes for
Patients with Psychiatric Disorders (STOPP) [Veterans Affairs HSR&D
IIR-09-335, Laurel Copeland, PI; 25% effort as co-I. – approved and
funded for FY09-FY10, $381,000. Nothing is known regarding perioperative risk
management and outcomes for veterans with severe mental illness, and by design,
the NSQIP is powerless to address this lack. This retrospective cohort study
uses VA administrative data from FY05 to FY09 to compare surgery rates and
postoperative outcomes (30-day mortality, myocardial infarction and acute
coronary syndrome, deep venous thrombosis or pulmonary embolism, ICU admission,
pneumonia, respiratory failure, sepsis, wound infection, readmission) by
pre-existing SMI status, adjusting for comorbidity and demographic variables.
Retrospective Database Examination of
Longitudinal Outcomes in Burned OEF/OIF Veterans [Veterans Affairs HSR&D
merit supplement] – Val Lawrence, PI. (10% effort as Co-I through June
2010). Additional aim to examine differential mortality rates across diagnostic
groups with death index data.
Role of Clinical Team Functioning and
Medication Adherence in Diabetes [Veterans Affairs HSR&D merit supplement
IIR-06-063, Mike Parchman, PI] – approved and funded for FY09-FY10,
$141,000 for supplement only (15% as Co-I leading new specific objective). Additional aim to examine clinical microsystem
learning and medication adherence.
Mortality Risk in Veterans with
Schizophrenia and Comorbid Diabetes [Veterans Affairs HSR&D merit
supplement, Laurel Copeland, PI] – approved and funded for FY09-FY10,
$50,290 (10% as Co-I). Additional aim to examine differential mortality rates
across diagnostic groups with death index data.
Feasibility of Tracking OEF/IEF
Transition into VA Care [Veterans Affairs HSR&D special short-term rapid
response proposal, Laurel Copeland, PI] – approved and funded for 2008,
$35,600 (10% effort as co-I). Using VA administrative data, track transition
rates of soldiers leaving DoD and entering the VA healthcare system.
Incorporating Medicare Pharmacy Data
into an Analysis of Potentially Inappropriate Prescribing in Elderly Veterans
[Veterans Affairs HSR&D merit supplement IIR 06-062, Mary Jo Pugh, PI]
– approved and funded for FY09-FY11, $223,600 (10% as Co-I). Incorporate
Medicare pharmacy data into the analysis to better account for aging veteran
population with dual system use.
Potentially Inappropriate Prescribing
in Elderly Veterans [Veterans Affairs IIR-06-062,
Systematic Review and Tracking Database
for CPG Implementation Research [Veteran Affairs II-R, Valerie Lawrence, PI]
– approved and funded for 2003-2008, $735,400 (5% effort as Co-I). Systematically review the literature on
organizational strategies of implementing evidence-based medicine into clinical
practice; designed to improve the quality of care provided to veterans with
QUERI diseases – high prevalence, chronic conditions (e.g., diabetes, CHF,
colon cancer, schizophrenia, depression, etc.)
Patterns
of Late-life Healthcare among VA patients with Schizophrenia [Veteran Affairs IIR-05-326, Laurel Copeland, PI] –
approved and funded for 2006-2008, $273,200 (20% effort as Co-I). Describe and
analyze current patterns of inpatient and outpatient medical, psychiatric, and
other care for veterans age 50+ with schizophrenia with or without diabetes;
determine correlates of care and relationship of patterns to mortality.
Improving substance abuse treatment in the borderland: early
intervention and follow-up in remote primary care clinics
[Veteran Affairs special
funding RFP; Steve Holliday, PI] – approved and funded for 2005-2007, ($736,990;
5% effort as Co-I, donated time until October 2006). Provide substance abuse interventions in a stepped care program for
veterans in remote clinics near the Mexico-Texas border. This demonstration
project will seek out at-risk veterans to engage them in treatment for
substance abuse (alcohol, tobacco, other drugs). The 3-year evaluated
implementation project will augment and integrate with clinical care currently
being offered in three satellite clinics in an impoverished, largely Hispanic
population.
Implementing integrated behavioral
health care for predominantly Hispanic OEF/OIF veterans [Veteran Affairs special funding
RFP; Steve Holliday, PI] – approved and funded for 2005-2007, ($586,442;
5% effort as Co-I, donated time until October 2006). Provide comprehensive, integrated care for returning OEF/OIF veterans,
including screening and treatment for substance abuse (alcohol, tobacco, other
drugs), depression, PTSD, and medical care as well as job services. The target
population lives in an underserved region of
Improving Medication Adherence among
Veterans with Schizophrenia. [Veterans Affairs grant #IIR01-074-1; Marcia
Valenstein, PI] – approved and funded for 2001-2005, 30% effort as
research associate. Multi-site (4 VA) 18-month intervention study designed to
improve medication adherence among veterans with serious mental illness;
primary component was a simple blister-pak, with some pharmacy education and
provider notification of missed refills.
Adopting Best-practices in Community Settings: The ABCs of Treatment for
Schizophrenia. [funding from Texas Department of Mental Health and Mental
Retardation (TDMHMR) and AstraZeneca; Alexander Miller, PI. Invited to serve as consultant on funded project
examining an intervention (cognitive adaptation training) designed to improve
functioning and treatment adherence, reduce inpatient utilization, and minimize
jail experiences in low-income patients with schizophrenia. One significant
analysis will focus on the cost-effectiveness of this intervention (contributed
effort as consultant).
Advanced Center for Interventions and
Service Research (ACISR) for Optimizing Long Term Outcomes in Bipolar Illness
Interventions in Hispanic Communities (NIH proposal - UTHSCSA Department of
Psychiatry P30 – funded May 2011] – 1) Cultural competency and
reduced ethnic disparity in psychiatric diagnosis for a predominantly Hispanic
region (John Zeber, PI – 10% effort, contributed); 2) Personalized
Interventions to Improve Treatment Engagement (Adherence) in Bipolar Disorder:
Academic and Community Sites (Jodi Gonzalez, PI – 7% effort as co-I
contributed). The ACISR will strengthen interdisciplinary interventions research
in bipolar disorders with a focus on the needs of the Hispanic American
community. Working with the South Texas community of patient groups, advocates,
and mental health providers and with Case Western Reserve University
collaborators, the ACISR will advance treatment and research methods in
effective strategies focused on sustained benefit and healthy function. The
ACISR will work to improve patients’ management of their bipolar illness, and
to expand the career opportunities of young investigators, particularly for
underrepresented racial and ethnic groups. These efforts will equip us to serve
as a national resource to advance the NIMH mission of reducing the burden of
bipolar illness, improve outcomes through translational research and broad dissemination,
expand public education and facilitate optimal public health planning.
Reports
:
§
Blow FC,
McCarthy JF, Valenstein M, Zeber JE, Gillon L. “Care for VA Patients
with Psychoses, 1999-2003” – Part of team that developed the database and
co-author on detailed annual report (5 editions) of all VA patients with
serious mental illness (N=191,000): demographics, psychiatric and medical
comorbidities, cost, utilization, mortality, functional status, access, and
pharmacy fills.
Institution and Research Community Contributions
& Service / Teaching Efforts
Invited
Presentations / Expert Panels:
Veterans Affairs HSR&D Center of
Excellence, Houston – invited to present current research findings at
monthly seminar (June 2011)
International Workshop on Costs and
Assessment in Psychiatry, Mental Health Policy and Economics – invited to
chair an oral presentation session (May 2011).
Scott & White, Department of Psychiatry
Grand Rounds (January 2011)
Introduction
to faculty and students, with discussion of new research center (CAHR), our
roles and contributions, and possible collaborations. (invited speaker).
UTHSCSA Department of Psychiatry Grand
Rounds (December 2010)
Broad
discussion of current findings influencing poor medication adherence in
patients with serious mental illness, incluidng use of administrative versus
primary data collection, along with the clinical implications of targerting
certain risk factors. (invited speaker).
Returning
Introduction
to PTSD center, introudction of our health services projects pertaining to post-deployment,
transition into VA, and surgery studies. (invited speaker).
Scott & White, Department of
Medicine Grand Rounds (October 2010)
Introduction
to faculty and students, with discussion of new research center (CAHR), our
roles and contributions, and possible collaborations. (invited speaker).
Lead Guest Editor, Depression
Treatment and Research (in progress, from invitation to lead a special
issue for an upcoming journal supplement – Fall 2011).
Shared
preliminary findings of a local research project, surveys from patients and
clinicians at 6 clincs regarding post-deployment health issues, at the annual
meeting of primary care providers involved in a collective research network
(invited speaker).
Multiple
risk factors for poor medication adherence in veterans with schizophrenia and
bipolar disorder, including demographic, financial, and psychosocial issues;
based upon the literature and our own work with VA administrative and survey
data. (invited speaker).
Medication Adherence Expert Consensus
Guideline Panel (Fall 2008)
Invited guest expert contributing to natinal working group project
to identify risk factors for madherence in patients with serious mental
illness, and strategies to address the persisent problem. Findings published in
special supplement of Journal of Clinical Psychiatry (v70, suppl 4, 2009).
Comprehensive Neuroscience Seminar on
Mental Illness and Pharmacy Benefits Policy (June 2007)
Special
sponsored seminar devoted to presenting research into the outcomes association
with medication copayments and other benefits for patients with psychiatric
conditions (invited speaker). Contributed to non-CME newsletters targeting
state and national mental health policy-makers.
Congressional Black Caucus / Center for
Minority Veterans: annual legislative meeting (September 21-23, 2005) Invited
panelist for forum discussing the implications of ethnic disparities in mental
health diagnosis and treatment, designed to foster research collaboration
between VA, academic and other organizations.
Other
Professional Activities / Leadeship Roles / Contributed Effort:
Editorial Board, World Journal of
Psychiatry (May 2011 – present)
IRB committee member and Chair, Central Texas
Veterans Health Care System, member (May 2011 – 2017)
International Society for
Pharmacoepidemiology Outcomes Research (ISPOR) and ISPOR National Working Group
on Medication Compliance, member (2007 – present): co-facilitator of two
special sections examining initial compliance
and the effect of copayments / financial incentives.
Coordinator, VERDICT Research Forum
(2007 – 2010): organized and led a weekly research seminar of internal
investigators and invited guest speakers.
Consultant, health services research
design and methods (2007 – present), several Practice Based Research
Networks: StarNet (primary care clinics), South Texas Psychitary (community psychiatrists),
Veterans Affiars mental health (VA providers), VA Women’s Research Network.
Consultant, several university projects
(2004 – 2012): unfunded participant role on different studies led by
Department of psychiatry investigators – study design dicussions,
defining variables and key outcomes, data analysis, manuscript presentation
(Drs. Miller, Velligan, Roache, Dassori, others).
Teaching,
mentoring, VA and university lectures, academic advisor roles:
Served as
mentor and consultant for two younger clinicians transitioning into research
and submitting VA career devlopment porposals (Jack Tsan PhD; Eni Williams,
PhD, PharmD), a resource for VA pharmacy residents, and conducting a monthly
seminar for junior Scott & White clinical researchers.
Created and obtained funding for a new Scott
& White minority pre-doctoral fellowship (2 011-2012): interviewed
candidates, developed structured program of mentoring, coursework, meetings
with senior VA, hosptial, and academic leaders.
Volunteered to
mentor a summer high school research intern (2011), part of a funded project
for an advanced junior college training program.
Doctoral
thesis / capstone project committee member: Gordon Black, Frontier School of
Nursing (Using the Health Promotion Model
to Reduce Appointment No-Shows in Rural Underserved Community Clinics).
Basic
statistics / methods lecture on cost-benefit and utility analyses for Scott
& White pulmonary fellows (January 2011).
In addition to
aforementioned SPH course development, grand rounds and invited lectures, I
have given numerous informal local research presentations for VA and university
colleagues, and contributed 2-3 formal lectures on health services research
methods as part of a standing course in the university’s Masters of
Science in Clinical Investigation program. (2009 – 2010).
Conference presentations (selected):
May 2011: International Society for
Pharmacoeconomics and Outcomes Research (Baltimore) – A Systematic
Literature Review of Behavioral Risk Factors Associated with Initial Medication
Adherence (poster)
April 2011: International Conference of
Schizophrenia Research (Colorado Springs) – Surgical Needs and Rates of
Common Procedures in Patients with Serious Mental Illness (oral presentation)
March 2011: HMO Research Network annual
meeting (Boston) – Outcomes of Cardiovascular Events in Two Systems of
Care (poster)
March 2011: International Workshop on
Costs and Assessment in Psychiatry, Mental Health Policy and Economics (Venice,
Italy) – Cost-Benefit Effects of Pharmacy Benefit Policies in Patients
with Schizophrenia (oral presentation)
February 2011: VA National Health
Services Research & Development Conference (Baltimore) – Medication
Adherence as a Measure of Comparative Effectiveness in Older Patients with
New-Onset Epilepsy (poster)
June 2010: Academy Health Annual
Research Meeting (Boston, MA) – 1) Cost-Related Medication Adherence and
Patients’ Experience with the Chronic Care Model (oral presentation - Best
Abstract, Quality & Efficiency theme; 2) OEF-OIF
Post-Deployment Health Care Needs in Community-based Primary Care Clinics
(poster).
April 2010: VA National Health Services
Research & Development Mental Health Conference (
November 2009: National Association of
Primary Care Research Group Annual Meeting (
June 2009: Academy Health Annual
Research Meeting (
June 2009: Critical Research Issues in
Latino Mental Health Conference (
March 2009: International Conference of
Schizophrenia Research (
February 2009: VA National Health
Services Research & Development Conference (Baltimore) – 1) A
Cost-Benefit Analysis of Higher Medication Copayments in Veterans with Schizophrenia
(oral presentation, plenary session); 2) Diabetes and Medication Adherence:
Understanding the Association between Perceived Drug Costs and Dimensions of
the Therapeutic Alliance (oral presentation); 3) Veterans with Serious Mental
Illness Undergoing Surgical Procedures: Prevalence Rates of Preoperative
Medical Comorbidities (poster).
October 2008: American Psychiatric
Association 60th Institute on Psychiatric Services (Chicago) –
Addressing
Barriers to Effective Drug Treatment in Public Mental Health (symposium).
May 2008: International Society for
Pharmacoeconomics and Outcomes Research (Toronto) – 1) Medication
Adherence, Ethnicity, and the Influence of Multiple Psychosocial and Financial
Barriers (poster); 2) Ethnicity and the Impact of Higher Medication Copayments
among Veterans with Schizophrenia (poster – received Best New
Investigator top award); 3) The Cost-Offset Effect of a Copayment Increase
among Veterans with Schizophrenia (poster).
March 2008: Critical Research Issues in
Latino Mental Health Conference (
February 2008: VA National Health
Services Research & Development Conference (Baltimore) – 1) Medication
Adherence, Ethnicity, and the Influence of Multiple Psychosocial and Financial
Barriers in Veterans with Bipolar Disorder (oral presentation); 2)
Cardiovascular Disease in Type-2 Diabetes: Using the UKPDS Methodology to
Determine Attributable Risk Variance Across 20 Community Clinics (poster); 3)
Patient Characteristics Affecting Perceived Access to Medical and Psychiatric
Care in Veterans with Bipolar Disorder (poster).
June 2007: Seventh International
Conference on Bipolar Disorder (Pittsburgh) – 1) Self-reported
Access to Medical and Psychiatric Care in Patients with Bipolar Disorder (oral
presentation); 2) Therapeutic Alliance Perceptions and Medication Adherence in
Patients with Bipolar Disorder (poster).
March 2007: International Conference of
Schizophrenia Research (
February 2006: VA National Health
Services Research & Development Conference (Washington DC) – 1)
Ethnicity, Perceptions of Therapeutic Alliance, and Adherence in Patients with
Bipolar Disorder (oral presentation); 2) Ethnicity and the Impact of Higher
Medication Copayments among Veterans with Schizophrenia (poster); 3) The Role
of Comorbid Psychiatric Conditions on Health Status in Veterans with Epilepsy
(poster).
April 2005: International Conference of
Schizophrenia Research (
February 2005: VA National Health
Services Research & Development Conference (
June 2004: Academy Health Conference
(San Diego) – 1) Atypical
Antipsychotics and Schizophrenia with Comorbid Substance Abuse; 2) Efforts to Recruit Patients with
Schizophrenia into Randomized Research Studies (posters).
May 2004: American Psychiatric
Association conference (
February 2003: VA National Health
Services Research & Development Conference (Washington DC) – 1) The Role of Ethnicity in the Diagnosis of Veterans with Serious Mental
Illness (oral presentation); 2) Aging and Utilization Patterns among Veterans
with Mental Illnesses (poster).
June 2002: Academy Health Conference (
April 2002: National
February 2002: VA National Health
Services Research & Development Conference (
September 2001:
February 2001: VA National Health
Services Research & Development Conference (
June 2000: Academy Health Conference (
Ad-hoc
Journal Reviewer:
American Journal of Preventive Medicine (March 2008 – present),
Scandinavian Journal of Public Health (March 2008 – present),
Comprehensive Psychiatry (December 2007 – present), Canadian Medical
Journal (September 2007 – present); Acta Neuropsychiatrica (June 2007
– present); Diabetes Care (May 2007 – present); Journal of General
Internal Medicine (April 2007 – present); Healthcare Management Review
(May 2006 – present); Clinical Therapeutics (September 2007 –
present); Journal of Behavioral Health Services & Research (March 2006
– present); Patient Education and Counseling (February 2006 –
present); Bipolar Disorder (May 2005 – present); Medical Care (December
2002 – present); American Journal of Managed Care (March 2001 –
present)
Scholarships,
Fellowships and Awards:
Ø Best Abstract for Quality & Efficiency: Improving
Processes of Care theme, Academy Health 2009 - Cost-Related Medication
Adherence and Patients’ Experience with the Chronic Care Model.
Ø Best New Investigator poster, ISPOR 2008 - Ethnicity and the
Impact of Higher Medication Copayments among Veterans with Schizophrenia.
Ø Agency for Health Care Policy and Research (ACHPR)
Fellowship – National Service Research Award, University of Michigan,
1998-2000.
Ø Alumni Scholarship – MHA program,
Ø First Interstate Scholarship / Dean’s List / Los Angeles
Philanthropic Society Scholarship –
Ø Scholar-Athlete Award Finalist –
Ø Most Valuable Player, Most Inspirational –
Intercollegiate tennis:
Professional
Membership and Activities:
¨ American Society of Hispanic Psychiatry, member (2008
– present)
¨ Academy of Health Services Research, member (2002 –
present)
¨ International Society for Pharmacoeconomics & Outcomes
Research (ISPOR), member (2005 – present)
¨ Leadership Committee -- MHA Program,
Peer-elected as Co-facilitator of the student run student organization.
Full responsibility for overseeing and coordinating various sub-committees
including budget and fundraising, orientation, graduation functions, student and
professional mentor activities, and academic seminars. Also assisted with
curriculum changes and admissions.
¨
Assisted in developing the itinerary for a two-week
comparative study experience of the Norwegian healthcare system, September
1997. Included, among others, were visits to the National Health Ministry, a
for-profit hospital, a rural health system, and an occupational health program.
Helped draft funding proposal and solicited financial support from the